{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:19:10Z","timestamp":1761664750047,"version":"build-2065373602"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Patolog\u00eda"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.patol.2020.04.005","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T22:06:04Z","timestamp":1595023564000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ber-EP4 staining in effusion cytology: A potential source of false positives"],"prefix":"10.1016","volume":"54","author":[{"given":"Cristina","family":"D\u00edaz del Arco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melchor","family":"Saiz-Pardo Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Ortega Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa Jes\u00fas","family":"Fern\u00e1ndez Ace\u00f1ero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.patol.2020.04.005_bib0320","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/1097-0142(20010225)93:1<68::AID-CNCR9009>3.0.CO;2-F","article-title":"Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears","volume":"93","author":"Lozano","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.patol.2020.04.005_bib0325","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1159\/000333982","article-title":"Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions","volume":"40","author":"Bailey","year":"1996","journal-title":"Acta Cytol"},{"key":"10.1016\/j.patol.2020.04.005_bib0330","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/1742-6413.83233","article-title":"Utility of a limited panel of calretinin and Ber-EP4 immunocytochemistry on cytospin preparation of serous effusions: a cost-effective measure in resource-limited settings","volume":"8","author":"Arora","year":"2011","journal-title":"Cytojournal"},{"key":"10.1016\/j.patol.2020.04.005_bib0335","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/dc.20202","article-title":"The combination of CEA EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion","volume":"32","author":"Dejmek","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0340","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jcp.43.3.213","article-title":"Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial","volume":"43","author":"Latza","year":"1990","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0345","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/dc.20203","article-title":"Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids","volume":"32","author":"Politi","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0350","article-title":"Peritoneal physiology","author":"Himmelfarb","year":"2019","journal-title":"Chronic Kidney Dis Dial Transplant"},{"key":"10.1016\/j.patol.2020.04.005_bib0355","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1357-2725(03)00242-5","article-title":"The mesothelial cell","volume":"36","author":"Mutsaers","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.patol.2020.04.005_bib0360","first-page":"166","article-title":"Malignant effusions","volume":"41","author":"Olopade","year":"1991","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.patol.2020.04.005_bib0365","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1164\/ajrccm.162.5.ats8-00","article-title":"Management of malignant pleural effusions","volume":"162","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.patol.2020.04.005_bib0013","doi-asserted-by":"crossref","DOI":"10.5858\/arpa.2019-0429-OA","article-title":"Malignancies in pleural peritoneal, and pericardial effusions: a 17-year single-institution review from 30085 specimens","author":"Dermawan","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.patol.2020.04.005_bib0375","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/dc.21006","article-title":"Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis","volume":"37","author":"Saleh","year":"2009","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2303.2007.00404.x","article-title":"Usefulness of ploidy AgNOR and immunocytochemistry for differentiating benign and malignant cells in serous effusions","volume":"18","author":"Palaoro","year":"2007","journal-title":"Cytopathology"},{"key":"10.1016\/j.patol.2020.04.005_bib0385","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/dc.2840080219","article-title":"The utility of ancillary techniques in effusion cytology","volume":"8","author":"Nance","year":"1992","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0390","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/dc.23903","article-title":"Molecular diagnostic techniques in cytopathology: from the bench to the patient's bedside","volume":"46","author":"D\u00edaz del Arco","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0395","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0344-0338(98)80065-4","article-title":"The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology","volume":"194","author":"Nagel","year":"1998","journal-title":"Pathol \u2013 Res Pract"},{"key":"10.1016\/j.patol.2020.04.005_bib0400","doi-asserted-by":"crossref","first-page":"739","DOI":"10.5858\/133.5.739","article-title":"Challenges in the interpretation of peritoneal cytologic specimens","volume":"133","author":"Lin","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.patol.2020.04.005_bib0405","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/dc.21489","article-title":"Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry","volume":"39","author":"Su","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0410","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.pas.0000208280.29291.34","article-title":"D2-40 is not a specific marker for cells of mesothelial origin in serous effusions","volume":"30","author":"Bassarova","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0415","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/B978-1-4160-5766-6.00022-4","article-title":"Immunohistology of the female genital tract","author":"Rabban","year":"2010","journal-title":"Diagnost Immunohistochem"},{"key":"10.1016\/j.patol.2020.04.005_bib0420","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00000478-199609000-00001","article-title":"Calretinin: a novel immunocytochemical marker for mesothelioma","volume":"20","author":"Doglioni","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0425","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncy.21439","article-title":"Wilms tumor 1\/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions","volume":"122","author":"Conner","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0430","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/modpathol.3880312","article-title":"Immunohistochemical diagnosis of papillary thyroid carcinoma","volume":"14","author":"Cheung","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0435","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.MP.0000037312.69565.24","article-title":"A comparison of CD10 to pCEA MOC-31, and hepatocyte for the distinction of malignant tumors in the liver","volume":"15","author":"Morrison","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0440","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/IJPM.IJPM_86_17","article-title":"Utility of MOC-31 monoclonal antibody in differentiating metastatic adenocarcinoma cells and reactive mesothelial cells in effusion cytology","volume":"61","author":"Patil","year":"2018","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.patol.2020.04.005_bib0445","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.21037\/jtd.2018.07.139","article-title":"Diagnostic benefits of the combined use of liquid-based cytology, cell block, and carcinoembryonic antigen immunocytochemistry in malignant pleural effusion","volume":"10","author":"Woo","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.patol.2020.04.005_bib0450","doi-asserted-by":"crossref","first-page":"e107741","DOI":"10.1371\/journal.pone.0107741","article-title":"Diagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in serous effusions: a meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.patol.2020.04.005_bib0455","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s004280050393","article-title":"Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies: evaluation of five epithelial markers","volume":"435","author":"Davidson","year":"1999","journal-title":"Virchows Arch"},{"key":"10.1016\/j.patol.2020.04.005_bib0460","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2303.1992.tb00033.x","article-title":"Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4","volume":"3","author":"De Angelis","year":"1992","journal-title":"Cytopathology"},{"key":"10.1016\/j.patol.2020.04.005_bib0465","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000325432","article-title":"Improved identification of malignant cells in serous effusions using a small robust panel of antibodies on paraffin-embedded cell suspensions","volume":"52","author":"Grefte","year":"2008","journal-title":"Acta Cytol"},{"key":"10.1016\/j.patol.2020.04.005_bib0470","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1097-0339(199607)15:1<33::AID-DC7>3.0.CO;2-R","article-title":"Immunocytochemical staining of smears and corresponding cell blocks from serous effusions: a follow-up and comparative investigation","volume":"15","author":"Jensen","year":"1996","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0475","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/dc.2840090509","article-title":"Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases","volume":"9","author":"Diaz-Arias","year":"1993","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0480","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5858\/2008-132-373-AOITC","article-title":"Application of immunohistochemistry to cytology","volume":"132","author":"Fowler","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.patol.2020.04.005_bib0485","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cncy.21518","article-title":"The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience","volume":"123","author":"Rossi","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0490","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/dc.20391","article-title":"Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion","volume":"34","author":"Ueda","year":"2006","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dc.10219","article-title":"Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block","volume":"28","author":"Gong","year":"2003","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0500","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ajcp\/109.1.85","article-title":"Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma: the M.D. Anderson experience and a critical review of the literature","volume":"109","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0505","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00000478-199206000-00007","article-title":"Immunoreactivity for Ber-EP4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas","volume":"16","author":"Gaffey","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0510","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5858\/arpa.2017-0092-OA","article-title":"Immunohistochemistry in peritoneal mesothelioma: a single-center experience of 244 cases","volume":"142","author":"Tandon","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.patol.2020.04.005_bib0515","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000478-200101000-00004","article-title":"Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis","volume":"25","author":"Carella","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0520","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00000478-199108000-00008","article-title":"Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma","volume":"15","author":"Sheibani","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0525","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.patol.2020.04.005_bib0530","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anndiagpath.2015.03.007","article-title":"Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma","volume":"19","author":"Chaouche-Mazouni","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0535","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/dc.23476","article-title":"Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology","volume":"44","author":"Oda","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0540","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cncy.20089","article-title":"Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology","volume":"118","author":"McKnight","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0545","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000447008","article-title":"Diagnostic usefulness of claudin-3 and claudin-4 for immunocytochemical differentiation between metastatic adenocarcinoma cells and reactive mesothelial cells in effusion cell blocks","volume":"60","author":"Kim","year":"2016","journal-title":"Acta Cytol"},{"key":"10.1016\/j.patol.2020.04.005_bib0550","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/cncy.22021","article-title":"Ancillary studies in pleural, pericardial and peritoneal effusion cytology","volume":"126","author":"Sundling","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0555","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cncy.21928","article-title":"A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma","volume":"126","author":"Kinoshita","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0560","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618808660","article-title":"Biomarkers in the diagnosis of pleural diseases: a 2018 update","volume":"12","author":"Porcel","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.patol.2020.04.005_bib0565","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jasc.2019.07.005","article-title":"Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, Part 2: Effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma","volume":"8","author":"Siddiqui","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0570","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/cyto.b.21258","article-title":"Screening of carcinoma metastasis by flow cytometry: a study of 238 cases","volume":"90","author":"Acosta","year":"2016","journal-title":"Cytom Part B Clin Cytom"},{"key":"10.1016\/j.patol.2020.04.005_bib0575","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0344-0338(11)80008-7","article-title":"Distinction of mesothelioma from carcinoma in pleural effusions: an immunocytochemical study on routinely processed cytoblock preparations","volume":"187","author":"Kuhlmann","year":"1991","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.patol.2020.04.005_bib0580","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/dc.2840110309","article-title":"Markers for metastatic adenocarcinoma in serous effusion specimens","volume":"11","author":"Shield","year":"1994","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0585","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1097-0339(199611)15:4<263::AID-DC3>3.0.CO;2-F","article-title":"Atypical cells in effusions: diagnostic value of cell image analysis combined with immunocytochemistry","volume":"15","author":"Matter-Walstra","year":"1996","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0590","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2303.1992.tb00051.x","article-title":"Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4 MCA-b-12 and EMA","volume":"3","author":"Stoop","year":"1992","journal-title":"Cytopathology"},{"key":"10.1016\/j.patol.2020.04.005_bib0595","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2303.1993.tb00101.x","article-title":"Comparison of monoclonal antibodies AUA1 and BER EP4 with anti-CEA for detecting carcinoma cells in serous effusions and distinguishing them from mesothelial cells","volume":"4","author":"Robinson","year":"1993","journal-title":"Cytopathology"},{"key":"10.1016\/j.patol.2020.04.005_bib0600","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/dc.2840100207","article-title":"Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens","volume":"10","author":"Maguire","year":"1994","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0605","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-0339(199708)17:2<115::AID-DC6>3.0.CO;2-F","article-title":"Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions","volume":"17","author":"Delahaye","year":"1997","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0610","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2303.2000.00211.x","article-title":"Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis","volume":"11","author":"Dejmek","year":"2000","journal-title":"Cytopathology"},{"key":"10.1016\/j.patol.2020.04.005_bib0615","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1309\/M877-QABM-D9GB-FJAX","article-title":"Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping","volume":"118","author":"Davidson","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0620","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1620\/tjem.206.31","article-title":"Ber-EP4 and anti-calretinin antibodies: a useful combination for differential diagnosis of various histological types of ovarian cancer cells and mesothelial cells","volume":"206","author":"Okamoto","year":"2005","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.patol.2020.04.005_bib0625","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/dc.20486","article-title":"The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant","volume":"34","author":"Aerts","year":"2006","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.patol.2020.04.005_bib0630","first-page":"817","article-title":"The role of immunohistochemistry in the diagnosis of neoplastic pleural effusions","volume":"53","author":"Dinu","year":"2012","journal-title":"Rom J Morphol Embryol"}],"container-title":["Revista Espa\u00f1ola de Patolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699885520300556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699885520300556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:05:49Z","timestamp":1761663949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699885520300556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1699885520300556"],"URL":"https:\/\/doi.org\/10.1016\/j.patol.2020.04.005","relation":{},"ISSN":["1699-8855"],"issn-type":[{"type":"print","value":"1699-8855"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ber-EP4 staining in effusion cytology: A potential source of false positives","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Patolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.patol.2020.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Anatom\u00eda Patol\u00f3gica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}